CD8A and neoplasm: To further elucidate the anti‐tumour mechanisms of CD103+CD8+ TRM, we analysed bulk RNA sequencing data obtained from flow cytometry‐sorted CD103+CD8+ TRM cells and CD103−CD8+ circulating T lymphocytes.